share_log

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A：並購重組委托聲明
美股sec公告 ·  05/03 17:27
Moomoo AI 已提取核心訊息
60 Degrees Pharmaceuticals, Inc. (60P) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be conducted virtually on July 16, 2024. The meeting will be accessible via live audio webcast, with no option for in-person attendance. Stockholders are invited to attend, register, obtain proxy materials, submit questions, and vote at the meeting. The company plans to make proxy materials available on or about June 6, 2024, primarily over the internet, to expedite delivery, reduce costs, and conserve resources. The meeting agenda includes the election of five directors, approval of an amendment to increase authorized shares under the 2022 Equity Incentive Plan, approval of a reverse stock split, modifications to the strike price of options for the CEO and CFO, issuance of options to a consultant, and the ratification of RBSM LLP as the independent auditor for the fiscal year ending December 31, 2024. The board recommends voting 'FOR' all proposals. The company emphasizes the importance of stockholder votes, regardless of attendance at the Annual Meeting.
60 Degrees Pharmaceuticals, Inc. (60P) has announced the scheduling of its 2024 Annual Meeting of Stockholders to be conducted virtually on July 16, 2024. The meeting will be accessible via live audio webcast, with no option for in-person attendance. Stockholders are invited to attend, register, obtain proxy materials, submit questions, and vote at the meeting. The company plans to make proxy materials available on or about June 6, 2024, primarily over the internet, to expedite delivery, reduce costs, and conserve resources. The meeting agenda includes the election of five directors, approval of an amendment to increase authorized shares under the 2022 Equity Incentive Plan, approval of a reverse stock split, modifications to the strike price of options for the CEO and CFO, issuance of options to a consultant, and the ratification of RBSM LLP as the independent auditor for the fiscal year ending December 31, 2024. The board recommends voting 'FOR' all proposals. The company emphasizes the importance of stockholder votes, regardless of attendance at the Annual Meeting.
60 Degrees Pharmicals, Inc.（60P）宣佈其2024年年度股東大會計劃於2024年7月16日虛擬舉行。會議將通過網絡直播進行觀看，沒有親自出席的選項。邀請股東參加、註冊、獲取代理材料、提交問題並在會議上投票。該公司計劃在2024年6月6日左右提供代理材料，主要通過互聯網提供，以加快交付、降低成本和節省資源。會議議程包括選舉五名董事，批准增加2022年股權激勵計劃下授權股份的修正案，批准反向股票拆分，修改首席執行官和首席財務官期權的行使價，向顧問發行期權，以及批准RBSM LLP作爲截至2024年12月31日的財政年度的獨立核數師。董事會建議對所有提案投贊成票。無論是否出席年會，該公司都強調股東投票的重要性。
60 Degrees Pharmicals, Inc.（60P）宣佈其2024年年度股東大會計劃於2024年7月16日虛擬舉行。會議將通過網絡直播進行觀看，沒有親自出席的選項。邀請股東參加、註冊、獲取代理材料、提交問題並在會議上投票。該公司計劃在2024年6月6日左右提供代理材料，主要通過互聯網提供，以加快交付、降低成本和節省資源。會議議程包括選舉五名董事，批准增加2022年股權激勵計劃下授權股份的修正案，批准反向股票拆分，修改首席執行官和首席財務官期權的行使價，向顧問發行期權，以及批准RBSM LLP作爲截至2024年12月31日的財政年度的獨立核數師。董事會建議對所有提案投贊成票。無論是否出席年會，該公司都強調股東投票的重要性。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息